Piramal Enterprises announces sale of BST-CarGel

Published On 2016-01-12 21:39 GMT   |   Update On 2016-01-12 21:39 GMT

MUMBAI: Piramal Enterprises announced sale of BST-CarGel from Piramal Healthcare (Canada) Ltd to Smith & Nephew, a global medical technology business.Through this transaction, an affiliate of Smith & Nephew plc will acquire ownership of all product and intellectual property assets related to BST-CarGel, a company statement said here.The company, however, did not disclose the value...

Login or Register to read the full article
MUMBAI: Piramal Enterprises announced sale of BST-CarGel from Piramal Healthcare (Canada) Ltd to Smith & Nephew, a global medical technology business.

Through this transaction, an affiliate of Smith & Nephew plc will acquire ownership of all product and intellectual property assets related to BST-CarGel, a company statement said here.

The company, however, did not disclose the value of transaction

BST-CarGel is a first-line cartilage repair product used along with microfracture and other bone marrow stimulation techniques for the initial treatment of most sizes of focal cartilage tears.

The transaction does not have a material impact on the financials of PEL, the release said.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News